| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.94M | $1.36M | $1.04M | $965.36K | $691.76K |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $783.45M | $162.05M | $56.40M | -$10.87M | -$17.81M |
| EPS (basic) | 16.5800 | 5.1100 | 1.8900 | -0.3700 | -0.8300 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |